Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.72B |
| 2 |
Apple
AAPL
|
+$1.98B |
| 3 |
Microsoft
MSFT
|
+$1.42B |
| 4 |
Alibaba
BABA
|
+$1.03B |
| 5 |
Amazon
AMZN
|
+$924M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$173M |
| 2 |
FedEx
FDX
|
+$150M |
| 3 |
Oracle
ORCL
|
+$139M |
| 4 |
Linde
LIN
|
+$132M |
| 5 |
PayPal
PYPL
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Healthcare | 7.18% |
| 3 | Consumer Discretionary | 7.09% |
| 4 | Financials | 5.3% |
| 5 | Industrials | 4.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
M&T Bank
MTB
$34.9B
| $20M | 0.01% |
156,723
-104,607
| -40% | -$11.9M |
|
1052
Dr. Reddy's Laboratories
RDY
$10.2B
| $19.9M | 0.01% |
1,397,525
+1,357,860
| +3,423% | +$18.3M |
|
1053
Bausch Health
BHC
$2.5B
| $19.9M | 0.01% |
955,989
+425,057
| +80% | +$7.93M |
|
1054
Tronox
TROX
$861M
| $19.9M | 0.01% |
1,359,397
+840,486
| +162% | +$9.78M |
|
1055
NovoCure
NVCR
$1.95B
| $19.8M | 0.01% |
114,708
+75,265
| +191% | +$10.3M |
|
1056
Travere Therapeutics
TVTX
$6.15B
| $19.8M | 0.01% |
727,176
-138,933
| -16% | -$3.24M |
|
1057
Gen Digital
GEN
$17.4B
| $19.8M | 0.01% |
953,488
+861,789
| +940% | +$17.4M |
|
1058
Diageo
DEO
$53.4B
| $19.8M | 0.01% |
124,746
+81,394
| +188% | +$12.1M |
|
1059
Maravai LifeSciences
MRVI
$1.26B
| $19.8M | 0.01% |
+705,698
| New | +$19.7M |
|
1060
Avis
CAR
$5.19B
| $19.7M | 0.01% |
527,507
+126,107
| +31% | +$4.43M |
|
1061
CALL
Coca-Cola
KO
$396B
| $19.7M | 0.01% |
358,700
-523,200
| -59% | -$27.1M |
|
1062
RingCentral
RNG
$5.6B
| $19.6M | 0.01% |
51,805
-59,832
| -54% | -$18.6M |
|
1063
Acadia Pharmaceuticals
ACAD
$5.11B
| $19.6M | 0.01% |
367,111
-224,421
| -38% | -$11.1M |
|
1064
Flowserve
FLS
$10.2B
| $19.6M | 0.01% |
531,866
+287,224
| +117% | +$9.4M |
|
1065
W.P. Carey
WPC
$16.3B
| $19.6M | 0.01% |
283,418
-446,986
| -61% | -$29.9M |
|
|
IAA
1066
DELISTED
IAA, Inc. Common Stock
IAA
| $19.5M | 0.01% |
300,581
+246,577
| +457% | +$14.8M |
|
|
UMPQ
1067
DELISTED
Umpqua Holdings Corp
UMPQ
| $19.5M | 0.01% |
1,286,234
-180,029
| -12% | -$2.47M |
|
1068
Immunovant
IMVT
$8.95B
| $19.5M | 0.01% |
421,184
-152,279
| -27% | -$7.04M |
|
|
SOGO
1069
DELISTED
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
| $19.4M | 0.01% |
2,385,260
+2,271,716
| +2,001% | +$19.7M |
|
|
MRSH
1070
Marsh
MRSH
$92.9B
| $19.4M | 0.01% |
166,094
+74,903
| +82% | +$8.51M |
|
|
SKX
1071
DELISTED
Skechers
SKX
| $19.4M | 0.01% |
540,673
+362,040
| +203% | +$12.3M |
|
1072
Jazz Pharmaceuticals
JAZZ
$16.5B
| $19.4M | 0.01% |
117,707
-137,105
| -54% | -$20.4M |
|
1073
Evercore
EVR
$11.2B
| $19.4M | 0.01% |
176,945
+135,966
| +332% | +$12.1M |
|
1074
Flex
FLEX
$39.4B
| $19.4M | 0.01% |
1,429,231
+857,344
| +150% | +$9.91M |
|
|
IVC
1075
DELISTED
Invacare Corporation
IVC
| $19.3M | 0.01% |
2,160,948
+835,699
| +63% | +$6.95M |
|
Similar funds
Israel Englander's Q4 2020 Portfolio in Review
As of Q4 2020, Israel Englander held 5,904 positions worth $138B, up 170,419% from $81.2M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $45.7B of net new capital in Q4 2020, opening 1,518 new positions and adding to 1,899 existing holdings. Its largest new stake was Sotera Health: 2,269,458 shares worth $62.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 6.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $173M trimmed.
- Israel Englander's largest Q4 2020 buy was Sotera Health: 2,269,458 shares worth $62.3M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $2.72B increase.
- Israel Englander's biggest Q4 2020 reduction was Keurig Dr Pepper, cutting an estimated $173M.
- Israel Englander fully exited Clover Health Investments in Q4 2020, selling an estimated $36.7M.
- Israel Englander's ten largest holdings make up 20% of its $138B portfolio in Q4 2020.
- Israel Englander opened 1,518 new positions and closed 754 in Q4 2020.
- Israel Englander's portfolio value rose 170,419% quarter-over-quarter to $138B.
Based on Millennium Management's 13F filing for Q4 2020, filed 16 Feb 2021.